Amyloidosis.
Amyloidosis is a heterogenous group of diseases characterized by deposition of a fibrillar, proteinaceous material, amyloid, in various tissues and organs. Increasing knowledge about the different proteins that constitute the amyloid fibrils has made it possible to classify amyloidosis by the fibril protein, which appears more rational than the traditional classification by its clinical expression. A serum protein is the precursor of the amyloid fibril protein in the various systemic forms of amyloidosis. Although the chemical composition of amyloid is presently well known, the pathogenetic processes that convert such proteins into a fibrillar form and lay them down in the tissues are far from clarified. This review describes the amyloid deposits, some putative pathogenetic mechanisms, and the clinical, therapeutic, and prognostic aspects of the most important forms of amyloid disease.
Husby
G
G
Department of Rheumatology, University and Regional Hospital of Tromsø, Norway.
D000682:Amyloid / Q000737:chemistry; D016564:Amyloid beta-Protein Precursor / Q000737:chemistry; D000686:Amyloidosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D000818:Animals; D006801:Humans; D011379:Prognosis; D013577:Syndrome
D000682:Amyloid; D016564:Amyloid beta-Protein Precursor